Unternehmen Global Blood Therapeutics, Inc.
Aktien
A14YE6
US37890U1088
GBT
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 457
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 63 | 01.05.21 | |
Corporate Officer/Principal | - | - | |
Jung Choi
PRN | Corporate Officer/Principal | 54 | 01.04.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 67 476 179 | 63 970 515 ( 94,80 %) | 0 | 94,80 % |
Unternehmenskontakt
Global Blood Therapeutics, Inc.
181 Oyster Point Boulevard
94080, South San Francisco
+650 741 7700
http://www.gbt.com/Sektor
% 1. Jan. | Kap. | |
---|---|---|
+9.16% | 45.97 Mrd. | |
+53.63% | 43.93 Mrd. | |
+11.20% | 42.34 Mrd. | |
-8.59% | 28.27 Mrd. | |
+16.40% | 27.18 Mrd. | |
-19.34% | 19.44 Mrd. | |
+13.95% | 13.83 Mrd. | |
+31.56% | 12.4 Mrd. | |
+10.63% | 11.45 Mrd. |